Panellists agreed that intervention is warranted in cases with Hb < 10 mg/dL, severe anaemia symptoms or underlying wAIHA‐associated diseases (Table 3). Short‐term goals include stabilising Hb, improving anaemia symptoms and inducing remission. The gene discussed is GSTM1; the disease is anemia.